Top 3 Health Care Stocks That Could Blast Off In December
Top 3 Health Care Stocks That Could Blast Off In December
12月份可能飆升的三大醫療保健股票
The most oversold stocks in the health care sector presents an opportunity to buy into undervalued companies.
醫療保健板塊中最超賣的股票爲買入被低估的公司提供了機會。
The RSI is a momentum indicator, which compares a stock's strength on days when prices go up to its strength on days when prices go down. When compared to a stock's price action, it can give traders a better sense of how a stock may perform in the short term. An asset is typically considered oversold when the RSI is below 30, according to Benzinga Pro.
RSI指標是一種動量指標，它比較了股票在價格上漲時的強度與在價格下跌時的強度。與股票的價格走勢進行比較，可以給交易者更好的了解股票短期內表現的良好程度。當RSI低於30時，資產通常被認爲是超賣的，根據Benzinga Pro的數據。
Here's the latest list of major oversold players in this sector, having an RSI near or below 30.
以下是本行業板塊最近的主要超賣股票列表，RSI接近或低於30。
Revolution Medicines Inc (NASDAQ:RVMD)
revolution medicines股票公司(NASDAQ:RVMD)
- On Dec. 3, Revolution Medicines priced its upsized $750 million public offering of 14,130,436 common stock at $46/share and pre-funded warrants. The company's stock fell around 17% over the past five days and has a 52-week low of $23.38.
- RSI Value: 27.88
- RVMD Price Action: Shares of Inter fell 6.9% to close at $48.23 on Tuesday.
- Benzinga Pro's real-time newsfeed alerted to latest RVMD news.
- Revolution Medicines定價其超額配售75000萬美元的14,130,436股普通股，價格爲46美元/股以及預先融資權證。該公司股價在過去五天下跌約17%，52周最低價爲23.38美元。
- RSI數值: 27.88
- RVMD價格走勢: inter股價週二下跌6.9%，收盤價爲48.23美元。
- Benzinga Pro的實時資訊提醒了最新的RVMD資訊。
Elanco Animal Health Inc (NYSE:ELAN)
Elanco Animal Health股份有限公司（紐交所: ELAN）
- On Dec. 2, Leerink Partners analyst Daniel Clark initiated coverage on Elanco Animal Health with a Market Perform rating and announced a price target of $14. The company's stock fell around 7% over the past five days and has a 52-week low of $11.40.
- RSI Value: 27.85
- ELAN Price Action: Shares of Elanco Animal Health fell 7.4% to close at $12.48 on Tuesday.
- Benzinga Pro's charting tool helped identify the trend in ELAN stock.
- 12月2日，Leerink Partners的分析師Daniel Clark對Elanco Animal Health進行了覆蓋，給予市場表現評級，並宣佈了14美元的目標價格。該公司股價在過去五天下跌約7％，52周最低價爲11.40美元。
- RSI數值：27.85
- ELAN現價表現：Elanco Animal Health的股價於週二下跌了7.4％，收於12.48美元。
- Benzinga Pro的圖表工具幫助識別了ELAN股票的趨勢。
Sotera Health Co (NASDAQ:SHC)
Sotera Health Co（納斯達克: SHC）
- On Nov. 5, Sotera Health reported quarterly earnings of 17 cents per share which missed the analyst consensus estimate of 18 cents per share. The company reported quarterly sales of $285.468 million which beat the analyst consensus estimate of $278.585 million. "I am pleased we achieved both top- and bottom-line growth for the third-quarter," said Chairman and Chief Executive Officer Michael B. Petras, Jr. "Our performance was largely in line with expectations, with an additional benefit at Nordion tied to the timing of cobalt-60 shipments. With most of the year behind us, we are reaffirming the 2024 revenue and EBITDA outlook ranges previously provided." The company's stock fell around 19% over the past month and has a 52-week low of $10.71.
- RSI Value: 29.58
- SHC Price Action: Shares of Sotera Health fell 3.2% to close at $12.83 on Tuesday.
- Benzinga Pro's signals feature notified of a potential breakout in SHC shares.
- Sotera Health報告第三季度每股盈利爲17美分，低於分析師共識預期的18美分。該公司報告第三季度銷售額爲28546.8萬美元，超過分析師共識預期的27858.5萬美元。公司董事長兼首席執行官Michael B. Petras, Jr.表示：「我很高興我們實現了第三季度的業績增長。我們的表現基本符合預期，努力工作的同時,Nordion由於鈷60發貨時間的關聯得到額外收益。隨着大部分年度已過去，我們重申了先前提供的2024年營業收入和EBITDA範圍。」該公司股價在過去一個月下跌了約19%，52周最低價格爲10.71美元。
- RSI值：29.58
- SHC股價走勢：Sotera Health股價週二下跌3.2%，收於12.83美元。
- Benzinga Pro的信號功能通知Sotera Health股票SHC可能出現突破。
Read More:
閱讀更多：
- Jim Cramer Prefers FedEx Over This Delivery Giant That 'Screwed Up A Lot Of Holiday Seasons'
- 吉姆·克萊默更喜歡聯邦快遞，而不是這家曾經「搞砸了很多個假期季節」的快遞巨頭。
譯文內容由第三人軟體翻譯。
以上內容僅用作資訊或教育之目的，不構成與富途相關的任何投資建議。富途竭力但無法保證上述全部內容的真實性、準確性和原創性。